Cost-Effectiveness of Pazopanib Versus Sunitinib in Egyptian Patients with Metastatic Renal Cell Carcinoma From the Health Insurance Perspective- A Markov Model
Abstract
Authors
G. Elsisi A. Hassouna A. Abu Taleb M. Elmahdawy S. Ibrahim